The Valley Desk

NCT02692755 · Interventional trial

Palbociclib / Letrozole or Fulvestrant in African American Women With HR+ HER2- Breast Cancer

Overall registry status Completed

Phase 2 · Phase 3

Conditions Hormone Receptor Positive HER-2 Negative Breast Cancer

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov